In/ Out Licensing Services

Bio-link Capital is a global R&D and licensing platform under clinical service center (CSC). Bio-link Capital is focusing on the fields of biomedical and high-end medical devices. Our pharmaceutical assets licensing channel reach the world, serving more than 3,000 global clients in the pharmaceutical field. Our employees and partners are located in Shanghai, Suzhou, Beijing, Taipei, Japan, Los Angeles, Boston, Germany, Switzerland, Canada, Australia and other regions. We are devoted to building the world's leading asset licensing platform to accelerate R&D, transactions and commercialization of novel drug, to benefit more patients. We have a mature business system structure, which can provide services including domestic and overseas pharmaceutical asset licesing transaction services, financial investment advisory, corporate merger and acquisition consulting, BD strategic consulting, product commercialization consulting, etc.